MET and non-small cell lung carcinoma: The frequently mutated genes in BM derived from NSCLC included TP53, EGFR, KRAS, CDKN2A, STK11, MET, PIK3CA, MYC, TERT, and CDKN2B, which we considered to be of most interest to target for intervention.